| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cb112a156941ee38ad88894c38370e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6ad5da4c975b15baef22da0e835807d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35bb9dbe473dde781e4d1f73cf644cb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9073f2f88e0b25bc71d779a63445442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c5b3042d3aaafe7f626bbcd985d534a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2a82c68f3222be237b9f41eeaf29818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21F1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D21F-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 |
| filingDate |
1985-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14135be492ab06068479e924c82596e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e40c696be6dfb154e22d1e458ebc6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0d4d630b62c82d9d4e4f87b417cb709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b810eb39d1f2c7df4d0a8acf93149a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8103caf4c82cd200843edddf6aed9734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65569639c6cbeffe5586f95e1be44a1a |
| publicationDate |
1986-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-231796-A5 |
| titleOfInvention |
ANTIBIOTIC COMPOUNDS, MANUFACTURING METHOD AND COMPOSITIONS CONTAINING SUCH SUBSTANCES |
| abstract |
The invention relates to a process for the preparation of acetylerythromycin stearate for use as a medicament. The aim of the invention is to provide a new Erythromycinderivates that does not have the disadvantages of the known Erythromycinpraeparate. According to the invention, acetylerythromycin stearate of the formula I is prepared by reacting erythromycin base with an acetyl halide in an organic solvent in the presence of a acid acceptor and preparing a stearate salt from the resulting ester without isolating it. |
| priorityDate |
1984-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |